A novel cartilage-based reference point for the recurrent laryngeal nerve: implication for preoperative risk stratification in posterior subcapsular thyroid tumors Authors: Qianqian Lu, Feiliang Wang, Xiaoquan Zhu, Jiankun Li, Weijing Li, Dongdong Wang, Yao Li, Yanyang Zhao, Gang Miao Published: 2026 ABSTRACT BackgroundProtecting the recurrent laryngeal nerve (RLN) is central in thyroidectomy, yet little is known about preoperative localization of the RLN and its role in assessing injury risk. We evaluated whether a novel cartilage-based landmark, the inferior cricoid-tracheal (ICT) point, located at the intersection of the lateral tracheal border and the inferior margin of the cricoid cartilage, approximates the laryngeal entry point (LEP) of the RLN and enables ultrasound-based measurement of tumor-nerve distance.MethodsThe study consisted of two independent cohorts. In the first cohort, the distance between the ICT point and the LEP was evaluated intraoperatively in 34 patients. In the second cohort, 78 patients with posterior subcapsular tumors underwent preoperative ultrasound measurement of the tumor-to-ICT point distance and intraoperative neuromonitoring (IONM) of RLN signals. An adverse RLN event was assessed using a decrease in signal amplitude of ≥ 50% as the threshold. Postoperative voice status was assessed clinically.ResultsThe mean ICT point-to-LEP distance was 2.27 ± 0.82 mm. Among the 78 patients with posterior subcapsular tumors, no IONM-defined adverse RLN events were observed in the 49 patients with a tumor-to-ICT point distance ≥ 2.5 mm. Among the 29 patients with a distance < 2.5 mm, 5 had adverse RLN events, whereas the remaining 24 had preserved RLN signals after careful dissection.ConclusionsPreoperative ultrasound measurement of the tumor-to-ICT point distance may provide an exploratory reference for assessing tumor-RLN proximity in posterior subcapsular thyroid tumors. In this study, a tumor-to-ICT point distance ≥ 2.5 mm was associated with no observed IONM-defined adverse RLN events. This cutoff may serve as a practical reference for preoperative risk assessment, although further validation in larger independent cohorts is still needed.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12957-026-04414-3. Introduction Recurrent laryngeal nerve (RLN) injury remains one of the most concerning complications of thyroidectomy [1–3]. Visual identification of the RLN is the consensus standard for preserving nerve integrity, as underscored in the American Thyroid Association guidelines [4]. However, the variable anatomy of the RLN complicates intraoperative identification. In contrast, the laryngeal entry point (LEP), where the RLN penetrates the inferior constrictor, is relatively constant and closely related to cartilaginous structures. Accordingly, cartilage-based landmarks have been investigated as potential surrogates for approximating the LEP and facilitating RLN identification. Previous studies have provided supportive evidence: Cakir et al. reported that the mean distance between the LEP and the inferior cornu measured 11.22 mm in women and 11.74 mm in men [5]. In a prospective series of 50 patients (72 RLNs), the LEP at the inferior edge of the cricoid cartilage was found to lie at a nearly constant distance from the trachea midline, averaging 20.7 ± 2.3 mm in women and 26.3 ± 2.1 mm in men [6]. Similarly, 71 patients (134 RLNs), corresponding distances were 21.3 ± 1.6 mm and 26.7 ± 2.5 mm, respectively [7]. Collectively, these findings suggest the stability of the LEP relative to fixed cartilaginous landmarks. In this study, we sought to identify a novel cartilage-based reference point located close to the LEP, with less interindividual variation, and more readily recognizable on routine ultrasound. We aimed to explore whether such a fixed anatomical landmark could be used as a practical preoperative sonographic reference for estimating tumor-RLN proximity. This may be of value in posterior subcapsular tumors, in which the relationship between the tumor and the RLN is clinically important for surgical planning and also warrants careful assessment when active surveillance is being considered [4, 8–10]. Methods Study design and patients Overall, this single-center observational study included 112 Chinese patients with papillary thyroid carcinoma (PTC) who underwent thyroidectomy, including 83 women and 29 men, with a mean (SD) age of 44.0 (11.9) years. This study consisted of two independent cohorts. In the first cohort, 34 consecutive patients who underwent intraoperative anatomical measurement between January 2024 and March 2024 were included to evaluate the relationship between the inferior cricoid-tracheal (ICT) point and the laryngeal entry point (LEP). In the second cohort, 78 consecutive patients with posterior subcapsular thyroid tumors who underwent preoperative ultrasonographic assessment and intraoperative recurrent laryngeal nerve (RLN) monitoring between June 2024 and June 2025 were included. Patients with a history of previous neck surgery were excluded. All procedures were performed by the same surgical team. Informed consent was obtained from all patients. The study was conducted in accordance with the Declaration of Helsinki and was approved by the Research Ethics Board of Beijing Hospital. Definition and identification of the ICT point The ICT point was defined as the intersection of the inferior margin of the cricoid cartilage and the lateral tracheal border (Fig. 1). This point was identified on preoperative ultrasonography using a predefined cartilage-based anatomical reference. Preoperative ultrasonographic identification of the ICT point was performed by a single sonographer with more than 10 years of experience in thyroid ultrasonography. Fig. 1Intraoperative measurement of the distance between the ICT point and the LEP of the RLN. A-B, Left panels, Representative intraoperative photographs from patients #APTC14 (A) and #APTC25 (B). The cross marks the cartilage-based reference point, the inferior cricoid-tracheal (ICT) point, defined as the intersection of the lateral tracheal border and the inferior margin of the cricoid cartilage. The arrow points to the LEP. A metric ruler is included for scale. A-B, Right panels, Schematic illustrations showing the relationship between the ICT point and the LEP of the RLN. RLN, Recurrent laryngeal nerve. LEP, laryngeal entry point Intraoperative measurement of the distance between the ICT point and the LEP of the RLN. A-B, Left panels, Representative intraoperative photographs from patients #APTC14 (A) and #APTC25 (B). The cross marks the cartilage-based reference point, the inferior cricoid-tracheal (ICT) point, defined as the intersection of the lateral tracheal border and the inferior margin of the cricoid cartilage. The arrow points to the LEP. A metric ruler is included for scale. A-B, Right panels, Schematic illustrations showing the relationship between the ICT point and the LEP of the RLN. RLN, Recurrent laryngeal nerve. LEP, laryngeal entry point Intraoperative identification and measurement In 34 patients (35 RLNs), the RLN was identified and confirmed with intraoperative neuromonitoring (IONM). The ICT point was palpated intraoperatively, and its distance to the LEP was measured independently by two attending surgeons using a sterile paper ruler. When the difference between the two measurements was ≤ 1 mm, the mean value was recorded; discrepancies > 1 mm were resolved by consensus. Preoperative ultrasound assessment In 78 patients with posterior subcapsular tumors, the ICT point was identified preoperatively with neck ultrasound in the supine position using either a Toshiba Aplio 500 system with a 5–14 MHz linear transducer or a Samsung RS80A system with a 3–12 MHz probe. The shortest distance from the ICT point to the tumor margin was measured. Outcome assessment In the clinical evaluation cohort, the main intraoperative outcome was an IONM-defined adverse RLN event, with a decrease in signal amplitude of ≥ 50% used as the event threshold [11–14]. Postoperative voice status was assessed by clinician evaluation and patient-reported hoarseness on postoperative day 3 (POD3), at 1 month (POM1), and at 3 months (POM3) after surgery. Laryngoscopic examination was not systematically performed in all patients. Statistical analysis Interobserver agreement for intraoperative measurements was evaluated using the intraclass correlation coefficient (ICC; two-way random-effects model for absolute agreement) and Bland-Altman analysis. Excellent reliability was defined as an ICC ≥ 0.90. Subgroup comparisons of the distance between the ICT point and the LEP by sex and body mass index (BMI, ≥ 28 kg/m2 vs. < 28 kg/m2, based on the Chinese criteria for obesity) were conducted using the Mann-Whitney U test. All tests were two-tailed. To determine the optimal threshold for the tumor-to-ICT point distance, we performed a receiver operating characteristic (ROC) curve analysis. The area under the curve (AUC) and the Youden index were calculated to identify the statistically optimal cutoff. Diagnostic performance, including sensitivity, specificity, and negative predictive value (NPV), was then evaluated. For the subgroup with a tumor-to-ICT point distance ≥ 2.5 mm, in which no IONM-defined adverse RLN events were observed, three distinct analytical approaches were used to estimate event risk. A decrease in signal amplitude of ≥ 50% was used as the threshold for an adverse RLN event. First, exact binomial confidence intervals were estimated using the Clopper-Pearson method by the binom package in R, providing a conservative upper-bound estimate. Second, Bayesian sensitivity analyses were performed using beta-binomial models. To address potential bias in prior selection, three prior distributions were tested: two literature-informed priors (Beta [5, 45], corresponding to an average risk of 9.8%, and Beta [13, 37], corresponding to a higher background risk of 26.0%) [15] and a non-informative Jeffreys prior (Beta [0.5, 0.5]) representing a state of total uncertainty. Posterior means and 95% credible intervals were calculated in R. Third, bootstrap resampling with 10,000 replicates was conducted using the boot package to assess the sampling variability of the maximum signal decrements and to estimate 95% confidence intervals. All analyses were conducted using R statistical software (version 4.2.2). Statistical significance was defined as a two-sided P < 0.05. Further methodological details are provided in the Supplementary Methods. Results Intraoperative measurement of the distance between the ICT point and the LEP Intraoperatively, the ICT point was consistently identified in 34 patients without obscuration or uncertainty (Fig. 1 and Supplementary Figs. 1–3). No additional dissection was required to establish this landmark. The mean (SD) distance between the ICT point and the LEP of the IONM-confirmed RLN was 2.27 (0.82) mm (range, 0.60–4.05 mm), with no significant variation by sex (Mann-Whitney U, two-tailed P = 0.88) or BMI category (≥ 28 kg/m2 vs. < 28 kg/m2, based on the Chinese criteria for obesity) (Mann-Whitney U, two-tailed P = 0.10). Interrater reliability was excellent (ICC = 0.987; 95% CI, 0.974–0.993). Preoperative ultrasound assessment of the distance from the ICT point to tumors abutting the posterior capsule The ICT point was consistently visualized on preoperative ultrasound in all 78 patients with posterior subcapsular tumors (Fig. 2A-C). The median tumor-ICT point distance was 4.75 mm (range, 0–31.10). ROC analysis showed an AUC of 0.77 (95% CI, 0.64–0.90). The maximum Youden index identified 2.3 mm as an optimal threshold, with a sensitivity of 1.0, specificity of 0.67, and NPV of 1.0. For greater clinical practicality and to provide a slightly more conservative safety margin, we used 2.5 mm as the descriptive cutoff in the subsequent analyses (Fig. 2D). At this threshold, sensitivity and NPV remained 1.0, with a specificity of 0.66. Fig. 2Preoperative ultrasound measurement of the distance from the ICT point to posterior subcapsular tumors. A, Ultrasound image from a healthy control at the level of the inferior margin of the cricoid cartilage. The ICT point is identified at the intersection of the lateral tracheal border and the cricoid plane. B-C, Representative preoperative ultrasound images from patients #BJPTC52 (B) and #BJPTC34 (C) with tumors abutting posterior thyroid capsule. The shortest distance from the ICT point to the tumor margin was measured along a tangent line, as illustrated in patient #BJPTC52. D, Scatterplot showing the relationship between tumor-to-ICT point distance and the IONM amplitude retention in 78 patients with posterior subcapsular tumors. The vertical dashed line denotes the descriptive cutoff at 2.5 mm. The horizontal dashed line indicates the 50% amplitude retention threshold used as the criterion for an adverse RLN event. Dark blue circles represent tumors with direct adherence to or invasion of the RLN, whereas light blue circles indicate tumors closely adjacent to the RLN but without adherence or invasion. RLN, recurrent laryngeal nerve; LEP, laryngeal entry point; IONM, intraoperative neuromonitoring Preoperative ultrasound measurement of the distance from the ICT point to posterior subcapsular tumors. A, Ultrasound image from a healthy control at the level of the inferior margin of the cricoid cartilage. The ICT point is identified at the intersection of the lateral tracheal border and the cricoid plane. B-C, Representative preoperative ultrasound images from patients #BJPTC52 (B) and #BJPTC34 (C) with tumors abutting posterior thyroid capsule. The shortest distance from the ICT point to the tumor margin was measured along a tangent line, as illustrated in patient #BJPTC52. D, Scatterplot showing the relationship between tumor-to-ICT point distance and the IONM amplitude retention in 78 patients with posterior subcapsular tumors. The vertical dashed line denotes the descriptive cutoff at 2.5 mm. The horizontal dashed line indicates the 50% amplitude retention threshold used as the criterion for an adverse RLN event. Dark blue circles represent tumors with direct adherence to or invasion of the RLN, whereas light blue circles indicate tumors closely adjacent to the RLN but without adherence or invasion. RLN, recurrent laryngeal nerve; LEP, laryngeal entry point; IONM, intraoperative neuromonitoring A decrease in IONM amplitude of ≥ 50% was used as the threshold for an adverse RLN event [11–14]. Among patients with a tumor-to-ICT point distance ≥ 2.5 mm (49/78 patients, 63%), all IONM amplitude reductions remained < 50%, with a mean decline of 3.5% (range, 0–26%). Among patients with a tumor-to-ICT point distance < 2.5 mm (29/78 patients, 37%), IONM-defined adverse RLN events occurred in five patients with tumor adherence or invasion, with signal loss of up to 80% (Fig. 2D; Table 1). Among these 5 patients, all reported hoarseness on POD3; 2 patients showed compensatory improvement at POM1, and no persistent hoarseness was reported at POM3 (Supplementary Table 1). In the remaining 24 patients without tumor invasion, careful dissection enabled complete tumor removal with preservation of RLN signals, and all IONM amplitude reductions remained < 50% (Fig. 2D; Table 1). Table 1Characteristics and intraoperative findings of 29 patients with preoperative ultrasound-measured tumor-to-ICT point distance < 2.5 mmPatient IDAge(y)SexLater-alityTumor size (cm)BMI (kg/m2)TNMstagePreoperative US Tumor-to-ICT Point Distance (mm)IntraoperativeTumor–RLN RelationshipIntraoperative ManagementIONM Signal RetentionBJPTC1648FRight1.618.73T1bN1aM02InvadingIncomplete dissection31%BJPTC2126MRight1.124.15T1bN0M02.1Adherent11%BJPTC2338MRight1.827.76T1bN1bM00Adherent42%BJPTC3439MLeft1.724.15T1bN1aM00Invading0%BJPTC4071FRight1.523.11T1bN1bM02.1Adherent47%BJPTC0133FRight2.222.83T2N1bM00AdjacentComplete dissection100%BJPTC0351MLeft1.924.21T1bN0M00Adjacent63%BJPTC0643FRight0.925.71T1aN0M00Adjacent79%BJPTC0855FLeft1.523.05T1aN0M00Adjacent95%BJPTC0938MLeft1.531.07T1bN1aM01.4Adjacent74%BJPTC1060FRight1.330.49T1bN0M01.1Adjacent99%BJPTC1441FRight0.923.26T1aN1aM02.1Adjacent100%BJPTC1540MRight3.324.39T2N1bM00Adjacent87%BJPTC2251FLeft2.224.03T2N1aM00Adjacent95%BJPTC2735FLeft2.928.52T2N1bM00Adjacent100%BJPTC2925FRight2.019.53T1bN1aM00Adjacent100%BJPTC3022MRight2.328.7T2N1aM00Adjacent92%BJPTC3650FRight1.327.59T1bN0M00Adjacent88%BJPTC3742FRight1.721.88T1bN1bM01.5Adjacent100%BJPTC4331FRight2.222.48T2N1aM00Adjacent83%BJPTC5331MLeft0.620.8T1aN0M02Adjacent100%BJPTC5958MRight1.125.35T1bN1bM01.7Adjacent100%BJPTC6249FRight1.625.61T1bN0M00Adjacent85%BJPTC6539FRight1.422.22T1bN1bM01.3Adjacent85%BJPTC6653FLeft0.825.34T1aN0M01.6Adjacent91%BJPTC6839FRight1.822.04T1bN1aM01Adjacent100%BJPTC7055FRight4.029.28T3aN0M00Adjacent100%BJPTC7141FLeft1.120.20T1bN1bM01.6Adjacent100%BJPTC7359FRight1.426.95T1bN1bM00Adjacent100%Abbreviations: ICT point inferior cricoid-tracheal point, F female, M, male, BMI body mass index, IONM intraoperative neuromonitoring, RLN recurrent laryngeal nerve, TNM stage tumor–node–metastasis (American Joint Committee on Cancer, AJCC, 8th edition), US ultrasound Table 1Characteristics and intraoperative findings of 29 patients with preoperative ultrasound-measured tumor-to-ICT point distance < 2.5 mmPatient IDAge(y)SexLater-alityTumor size (cm)BMI (kg/m2)TNMstagePreoperative US Tumor-to-ICT Point Distance (mm)IntraoperativeTumor–RLN RelationshipIntraoperative ManagementIONM Signal RetentionBJPTC1648FRight1.618.73T1bN1aM02InvadingIncomplete dissection31%BJPTC2126MRight1.124.15T1bN0M02.1Adherent11%BJPTC2338MRight1.827.76T1bN1bM00Adherent42%BJPTC3439MLeft1.724.15T1bN1aM00Invading0%BJPTC4071FRight1.523.11T1bN1bM02.1Adherent47%BJPTC0133FRight2.222.83T2N1bM00AdjacentComplete dissection100%BJPTC0351MLeft1.924.21T1bN0M00Adjacent63%BJPTC0643FRight0.925.71T1aN0M00Adjacent79%BJPTC0855FLeft1.523.05T1aN0M00Adjacent95%BJPTC0938MLeft1.531.07T1bN1aM01.4Adjacent74%BJPTC1060FRight1.330.49T1bN0M01.1Adjacent99%BJPTC1441FRight0.923.26T1aN1aM02.1Adjacent100%BJPTC1540MRight3.324.39T2N1bM00Adjacent87%BJPTC2251FLeft2.224.03T2N1aM00Adjacent95%BJPTC2735FLeft2.928.52T2N1bM00Adjacent100%BJPTC2925FRight2.019.53T1bN1aM00Adjacent100%BJPTC3022MRight2.328.7T2N1aM00Adjacent92%BJPTC3650FRight1.327.59T1bN0M00Adjacent88%BJPTC3742FRight1.721.88T1bN1bM01.5Adjacent100%BJPTC4331FRight2.222.48T2N1aM00Adjacent83%BJPTC5331MLeft0.620.8T1aN0M02Adjacent100%BJPTC5958MRight1.125.35T1bN1bM01.7Adjacent100%BJPTC6249FRight1.625.61T1bN0M00Adjacent85%BJPTC6539FRight1.422.22T1bN1bM01.3Adjacent85%BJPTC6653FLeft0.825.34T1aN0M01.6Adjacent91%BJPTC6839FRight1.822.04T1bN1aM01Adjacent100%BJPTC7055FRight4.029.28T3aN0M00Adjacent100%BJPTC7141FLeft1.120.20T1bN1bM01.6Adjacent100%BJPTC7359FRight1.426.95T1bN1bM00Adjacent100%Abbreviations: ICT point inferior cricoid-tracheal point, F female, M, male, BMI body mass index, IONM intraoperative neuromonitoring, RLN recurrent laryngeal nerve, TNM stage tumor–node–metastasis (American Joint Committee on Cancer, AJCC, 8th edition), US ultrasound Characteristics and intraoperative findings of 29 patients with preoperative ultrasound-measured tumor-to-ICT point distance < 2.5 mm Abbreviations: ICT point inferior cricoid-tracheal point, F female, M, male, BMI body mass index, IONM intraoperative neuromonitoring, RLN recurrent laryngeal nerve, TNM stage tumor–node–metastasis (American Joint Committee on Cancer, AJCC, 8th edition), US ultrasound Among patients with a tumor-to-ICT point distance ≥ 2.5 mm, the upper 95% confidence limit of the event risk was estimated at 7.3% by exact binomial analysis. Bayesian sensitivity analyses yielded consistent results. Using a literature-informed prior based on a higher background injury rate of 26% [15], the posterior probability of nerve preservation remained 87% (95% CI, 80% − 92.7%). Using a completely neutral statistical model (Jeffreys prior) that relies solely on our observed data, the estimated average risk was 1.0% (95% credible interval, 0% − 4.5%). Bootstrap resampling (10,000 iterations) yielded 95% confidence intervals of 13.5% to 26.4% for the maximum observed signal decrease in this subgroup. Overall, these analyses consistently supported the association between a tumor-to-ICT point distance ≥ 2.5 mm and a low frequency of adverse intraoperative RLN events in this cohort. Discussion To our knowledge, this is the first study to translate an intraoperatively validated cartilage-based landmark of the RLN into a preoperative ultrasound method for assessing tumor-nerve distance in posterior subcapsular thyroid tumors. In our cohort, the ICT point was located a mean of 2.27 ± 0.82 mm from the LEP, with no significant variation by sex or BMI category. By linking intraoperative validation with preoperative imaging, the ICT point may serve as a reproducible and clinically accessible landmark for anticipating RLN proximity in posterior subcapsular tumors. A key issue in interpreting the present findings was the derivation and interpretation of the 2.5 mm cutoff. ROC analysis suggested 2.3 mm as the statistically optimal threshold. However, we used 2.5 mm as the descriptive clinical cutoff because this value was close to the observed mean ICT point-to-LEP distance and provided a slightly more conservative reference for preoperative assessment. In addition, the 2.5 mm threshold retained a sensitivity and negative predictive value of 1.0 in this cohort. Moreover, the additional statistical analyses provided consistent support for this observation. Exact binomial analysis showed an upper 95% confidence limit of 7.3% for adverse intraoperative events in the subgroup with a tumor-to-ICT point distance ≥ 2.5 mm. Bayesian sensitivity analyses yielded consistent findings, including under a non-informative Jeffreys prior. These results suggest that a distance of ≥ 2.5 mm may be useful as a practical reference in this cohort, while still requiring confirmation in larger independent studies. Previous anatomical work in a cadaveric dissection of 64 RLNs described a reference point at the junction of the inferior border of the cricopharyngeal muscle and the inferior cornu of thyroid cartilage, with a mean distance of 2.3 ± 0.85 mm from the RLN [16]. However, such a landmark involving soft tissue may shift with neck position or tissue retraction, and is not easily visualized sonographically. By contrast, the ICT point is based on a relatively fixed cartilaginous landmark. This feature may make it more readily identifiable on routine ultrasound and may be less affected by overlying soft tissue variation. On the other hand, attempts to directly visualize the RLN with preoperative ultrasound have been reported but remain technically limited due to the nerve’s fine caliber, deep course, low tissue contrast, and surrounding hyperechoic connective tissues [17, 18]. High-resolution ultrasonography (HRUS) has been explored to improve detectability, with one single-center study reporting RLN visibility in approximately 84% of cases at the level of the cricoid cartilage [18], yet HRUS is not widely adopted in routine thyroid practice, and intraoperative HRUS remains impractical. By focusing on fixed cartilaginous landmarks rather than direct nerve imaging, our approach may provide a more accessible method for preoperative assessment. In our cohort, the tumor-to-ICT point distance also showed potential value for preoperative risk stratification. Among patients with a tumor-to-ICT point distance < 2.5 mm, 5 had tumor adherence or invasion associated with IONM-defined adverse RLN events. In the remaining 24 patients without invasion, RLN preservation was achieved with careful dissection, including 14 patients with an ultrasound-measured distance of 0 mm. These findings suggest that a shorter tumor-to-ICT point distance may indicate a closer tumor-RLN relationship, but they also show that nerve preservation may still be achievable in selected cases when direct invasion is absent. Accordingly, the 2.5 mm cutoff should be interpreted as an exploratory and clinically practical reference rather than as a strict decision threshold. The potential clinical value of the ICT point may lie mainly in its use as an adjunctive preoperative reference rather than as a stand-alone determinant of management. A shorter tumor-to-ICT point distance may suggest a closer tumor-RLN relationship and may therefore support more detailed preoperative counseling and more cautious intraoperative nerve identification and protection. At the present stage, this landmark should be interpreted as a practical reference rather than a formal decision threshold, and its role in guiding specific management pathways still requires further validation. This study has several limitations. First, it was a single-center study with a modest sample size, which may limit the generalizability of the findings. Second, preoperative ultrasonographic identification of the ICT point was performed by a single sonographer, and interobserver variability for ultrasound-based identification was not formally assessed. Although patients with different BMI levels were included in the cohort, the influence of operator variation and patient-related anatomical factors still requires further evaluation. Third, postoperative vocal cord function was not systematically assessed by laryngoscopy. Postoperative voice outcomes were evaluated mainly by clinician assessment and patient-reported symptoms on POD3, at POM1, and at POM3. Therefore, although short-term voice changes after IONM-defined adverse RLN events were documented clinically, transient or permanent vocal cord palsy could not be formally determined in all patients, and the relationship between intraoperative IONM changes and objective postoperative vocal cord dysfunction could not be fully established in this cohort. Finally, the study population was restricted to PTC with posterior subcapsular tumors, which may limit the applicability of the findings to other tumor locations or pathological types. In addition, because of the limited sample size and small number of adverse RLN events, more detailed stratified analysis around the 2.5 mm cutoff could not be reliably performed. Larger multicenter studies are needed to further validate the reproducibility, predictive value, and clinical utility of this landmark. In conclusion, the ICT point may serve as a reproducible landmark for approximating the LEP in posterior subcapsular thyroid tumors. In this cohort, a tumor-to-ICT point distance of ≥ 2.5 mm was associated with no observed IONM-defined adverse RLN events. This cutoff may serve as a practical reference for preoperative risk assessment, although further validation in larger independent cohorts is still needed. Supplementary Information Supplementary Material 1. Supplementary Material 1. Supplementary Material 2. Supplementary Material 2. Supplementary Material 3. Supplementary Material 3. Supplementary Material 4. Supplementary Material 4.